Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease

Details for Australian Patent Application No. 2010264695 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Baudoux, Guy Jean Marie Fernand Pierre; Colau, Brigitte Desiree Alberte; Dendouga, Najoua; Giannini, Sandra; Lecrenier, Nicolas Pierre Fernand

Agent Shelston IP

Pub. Number AU-A-2010264695

PCT Pub. Number WO2010/149752

Priority 61/220,358 25.06.09 US; 61/239,880 04.09.09 US; 61/322,102 08.04.10 US

Filing date 24 June 2010

Wipo publication date 29 December 2010

International Classifications

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/149752 Priority application(s): WO2010/149752

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010264698-1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17

2010264690-Method of forming a cured coating composition on an automobile component